Artificial Intelligence
Cambridge AI Club - October Theme - Commercialisation of AI
The AI Club brings together the Biomedical AI and Machine Learning community in Cambridge to discuss common themes and explore different topics and methodologies. ...
eg technology launch EU office as they partner with Galway-based PorterShed
eg technology is pleased to announce our partnership with PorterShed in Galway, Ireland, as we open our first office directly servicing the EU market. ...
The Future of Education Consortium in Cambridge
The Future of Education Consortium meets in Cambridge on September 10 with a dynamic community of forward-thinking educators, technologists, and opinion leaders dedicated to shaping the educational landscape. ...
Cambridge Kinetics wins share of £32m Innovate UK grant to improve productivity with AI
Cambridge Kinetics win competitive award for Innovate UK grant funding to develop artificial intelligence and improve productivity in creative industries. ...
Monumo hosts Chief Scientific Advisor for DSIT
Monumo hosted its first visit from Professor Chris Johnson, the Chief Scientific Advisor for the Department of Science, Innovation and Technology (DSIT). Professor Johnson visited our Cambridge office to learn more about how we are coupling deeptech innovation with engineering expertise...
Growing demand on dark web for AI abuse images
New study found a clear desire among online offenders to learn new technologies.
Darktrace introduces new Global Partner Program
Darktrace Defenders Partner Program builds upon strategic investments to accelerate partner-first go-to-market strategy. ...
New guide on using generative AI for teachers and schools from Raspberry Pi Foundation
The world of education is loud with discussions about the uses and risks of generative AI — tools for outputting human-seeming media content such as text, images, audio, and video. ...
Darktrace recognised as the winner of 2024 Microsoft UK Partner of the Year
Darktrace announces it has won the UK 2024 Microsoft Partner of the Year Award.
Healx announces $47 million Series C financing and FDA clearance of phase 2 IND for Neurofibromatosis type 1 trial
Cambridge, UK – Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, announced it has raised $47 million in a Series C round. ...